415 related articles for article (PubMed ID: 15338271)
1. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
Teismann P; Schulz JB
Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of glial cells in Parkinson's disease.
Teismann P; Tieu K; Cohen O; Choi DK; Wu DC; Marks D; Vila M; Jackson-Lewis V; Przedborski S
Mov Disord; 2003 Feb; 18(2):121-9. PubMed ID: 12539204
[TBL] [Abstract][Full Text] [Related]
3. The influence of microglia on the pathogenesis of Parkinson's disease.
Long-Smith CM; Sullivan AM; Nolan YM
Prog Neurobiol; 2009 Nov; 89(3):277-87. PubMed ID: 19686799
[TBL] [Abstract][Full Text] [Related]
4. Glial reactions in Parkinson's disease.
McGeer PL; McGeer EG
Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
[TBL] [Abstract][Full Text] [Related]
5. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
7. Glial cell response: A pathogenic factor in Parkinson's disease.
Wu DC; Tieu K; Cohen O; Choi DK; Vila M; Jackson-Lewis V; Teismann P; Przedborski S
J Neurovirol; 2002 Dec; 8(6):551-8. PubMed ID: 12476349
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.
Knott C; Stern G; Wilkin GP
Mol Cell Neurosci; 2000 Dec; 16(6):724-39. PubMed ID: 11124893
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald A; Lotharius J
Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
[TBL] [Abstract][Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammatory processes in Parkinson's disease.
Hirsch EC; Hunot S; Hartmann A
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S9-S15. PubMed ID: 15885630
[TBL] [Abstract][Full Text] [Related]
12. The role of glial cells in Parkinson's disease.
Vila M; Jackson-Lewis V; Guégan C; Wu DC; Teismann P; Choi DK; Tieu K; Przedborski S
Curr Opin Neurol; 2001 Aug; 14(4):483-9. PubMed ID: 11470965
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration and inflammation in Parkinson's disease.
Phani S; Loike JD; Przedborski S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
[TBL] [Abstract][Full Text] [Related]
14. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
[TBL] [Abstract][Full Text] [Related]
15. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
[TBL] [Abstract][Full Text] [Related]
17. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
Kim S; Moon M; Park S
J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
[TBL] [Abstract][Full Text] [Related]
19. [Inflammation and Parkinson's disease].
Barcia González C; Herrero Ezquerro MT
Rev Neurol; 2004 Mar 16-31; 38(6):545-53. PubMed ID: 15054720
[TBL] [Abstract][Full Text] [Related]
20. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]